Dermapharm Holding SE (ETR:DMP)

Dermapharm Holding SE Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 1, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,965	2,280	2,020	4,808	3,067	2,140
Market Cap Growth	-10.66%	12.85%	-57.98%	56.78%	43.30%	75.11%
Enterprise Value	2,877	3,258	2,493	5,294	3,584	2,599
Last Close Price	36.50	41.32	35.80	81.41	51.26	35.13
PE Ratio	21.74	36.55	15.05	22.94	35.73	27.72
Forward PE	14.83	17.44	10.61	22.27	25.14	20.13
PS Ratio	1.68	1.98	1.94	5.01	3.79	3.00
PB Ratio	3.38	4.18	3.79	9.62	9.45	7.52
P/TBV Ratio	-	-	41.96	310.95	-	-
P/FCF Ratio	12.51	12.82	8.10	25.42	33.96	39.51
P/OCF Ratio	9.56	10.39	7.00	19.20	23.39	21.27
EV/Sales Ratio	2.45	2.83	2.40	5.51	4.43	3.64
EV/EBITDA Ratio	11.89	14.79	8.24	16.95	23.12	19.86
EV/EBIT Ratio	13.36	16.87	8.82	17.89	25.58	21.58
EV/FCF Ratio	18.32	18.31	9.99	27.98	39.69	47.98
Debt / Equity Ratio	1.74	1.98	0.97	1.16	1.87	1.95
Debt / EBITDA Ratio	4.26	4.77	1.69	1.83	3.81	4.11
Debt / FCF Ratio	6.53	6.07	2.07	3.07	6.72	10.24
Asset Turnover	0.55	0.64	0.74	0.73	0.71	0.82
Inventory Turnover	1.29	1.55	1.57	1.56	1.86	2.30
Quick Ratio	0.65	0.75	1.18	1.61	1.39	1.68
Current Ratio	1.66	1.60	2.45	3.34	3.01	3.45
Return on Equity (ROE)	15.75%	11.24%	25.69%	50.68%	28.21%	28.79%
Return on Assets (ROA)	6.26%	6.76%	12.53%	14.06%	7.72%	8.61%
Return on Capital (ROIC)	8.23%	9.03%	16.60%	18.39%	9.89%	10.76%
Return on Capital Employed (ROCE)	12.30%	10.90%	23.70%	23.60%	12.80%	12.80%
Earnings Yield	4.61%	2.74%	6.64%	4.36%	2.80%	3.61%
FCF Yield	7.99%	7.80%	12.35%	3.93%	2.94%	2.53%
Dividend Yield	2.41%	2.13%	2.93%	2.67%	1.72%	2.28%
Payout Ratio	52.30%	90.64%	87.04%	22.61%	50.19%	53.70%
Buyback Yield / Dilution	-0.23%	-	-	-	-	-0.79%
Total Shareholder Return	2.19%	2.13%	2.93%	2.67%	1.72%	1.49%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.